Neumora Therapeutics (NMRA) Current Leases (2022 - 2026)
Neumora Therapeutics (NMRA) recorded quarterly Current Leases of $291000.0 in Q1 2026, up 2.46% quarter-over-quarter from $284000.0 in Q4 2025, and down 68.98% on a YoY basis from $938000.0 in Q1 2025.
Neumora Therapeutics (NMRA) Current Leases (2022 - 2026) Analysis & Trends
Neumora Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $291000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 68.98% year-over-year to $291000.0; the TTM figure through Mar 2026 stood at $291000.0 (down 68.98% YoY), while the FY2025 annual figure was $284000.0, down 84.67% from the prior year.
- Current Leases was $291000.0 for Q1 2026 at Neumora Therapeutics, up from $284000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.6 million in Q2 2024 to a low of $171000.0 in Q2 2025.
- Historically, Current Leases has averaged $2.0 million across 5 years, with a median of $2.3 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Current Leases rose 0.24% in 2023, then plunged 95.26% in 2025.
- A 5-year view of Current Leases shows it stood at $3.4 million in 2022, then grew by 0.24% to $3.4 million in 2023, then sank by 45.15% to $1.9 million in 2024, then sank by 84.67% to $284000.0 in 2025, then increased by 2.46% to $291000.0 in 2026.
- The last three Current Leases figures came in at $291000.0 (Q1 2026), $284000.0 (Q4 2025), and $256000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Neumora Therapeutics | 320.17 Mn | 320.17 Mn | - | 291,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 291,000.00 |
| Dec 31, 2025 | 284,000.00 |
| Sep 30, 2025 | 256,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 938,000.00 |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | 3.61 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Dec 31, 2022 | 3.37 Mn |